Gut microbiota-driven IL-17A production by hepatic γδ T cells enhances neutrophil defense against systemic Staphylococcus aureus infection

Na Pan, Xing Su, Yifei Meng, Yanchen Liang, Xiye Chen, Haochi Zhang, Y. N. WangVirulence 2026 · DOI

TL;DR

This study uncovers a crucial gut-liver communication pathway where gut microbes prime hepatic γδ T cells to produce IL-17A. This IL-17A then recruits neutrophils to the liver, forming a vital defense against systemic Staphylococcus aureus infections. This highlights a potential therapeutic strategy using specific gut bacteria or their metabolites to boost host immunity.

What Problem Does This Paper Address?

Staphylococcus aureus bloodstream infections are a major clinical challenge, often leading to high mortality, especially with rising antibiotic resistance. While the gut microbiome is known to influence systemic immunity, the precise mechanisms by which it protects against invasive bacterial infections, particularly in the liver, remain unclear. The liver is a critical site for clearing blood-borne pathogens, and understanding how the gut microbiota primes this hepatic defense is essential for developing new strategies to combat these dangerous infections.

Methods

The researchers employed a multi-pronged approach using mouse models:

  • Microbiota Depletion and Reconstitution: Antibiotic treatment (ABX) was used to disrupt the gut microbiota, and fecal microbiota transplantation (FMT) was used to restore it.
  • Bacterial Challenge: Mice were infected intravenously (i.v.) with S. aureus (including a GFP-labeled strain for imaging).
  • Immune Cell Analysis: Flow cytometry (FCM) was used to quantify specific immune cell populations (γδ T cells, Th17 cells, neutrophils) and their cytokine production (IL-17A) in the liver.
  • Cytokine and Chemokine Measurement: ELISA was used to measure levels of IL-17A, KC, MIP-2, and MPO in liver tissue.
  • Bacterial Load and Histopathology: Bacterial burdens in various organs were quantified, and liver and kidney tissues were examined histologically (H&E staining) to assess damage.
  • Microbiota Analysis: 16S rRNA gene sequencing was used to characterize gut microbial composition.
  • Indole Metabolite Analysis: Kovac's reagent assay was used to detect indole production by isolated bacteria.
  • Genetic Manipulation: Mice deficient in IL-17A ( Il17a<sup>-/-</sup> ) and γδ T cells ( Tcrδ<sup>-/-</sup> ) were used to dissect the roles of these components.
  • Recombinant Cytokine Administration: Recombinant IL-17A (rIL-17A) was administered to mice to assess its protective effects.

Datasets

Not explicitly discussed as distinct datasets for training/evaluation in the context of machine learning. The study generated data from mouse experiments, including:

  • 16S rRNA gene sequencing data from fecal samples to characterize gut microbial communities.
  • Flow cytometry data quantifying immune cell populations and cytokine expression.
  • ELISA data for cytokine and chemokine levels.
  • Bacterial CFU counts from various organs.
  • Histological images of liver and kidney tissues.

The 16S rRNA sequencing data has been deposited in the NCBI Sequence Read Archive (SRA) and BioProject number PRJNA1244564.

Key Insights and Ideas

  • Gut-Liver Axis is Crucial for Early Defense: The study reveals a direct link between the gut microbiome and the liver's ability to combat systemic bacterial infections early on.
  • γδ T Cells as Early Responders: Hepatic γδ T cells, not just adaptive T helper cells, are identified as key players in producing IL-17A rapidly upon bacterial challenge, forming an "immunological firewall."
  • IL-17A as the Mediator: IL-17A is shown to be the critical cytokine that bridges the gut microbiota signal to neutrophil recruitment in the liver.
  • Limosilactobacillus reuteri as a Protective Probiotic: This specific commensal bacterium is highlighted as a key contributor to activating the γδ T cell-IL-17A-neutrophil axis and restoring host defense.
  • Indole Metabolites as Microbial Signals: The study points to indole metabolites produced by L. reuteri as the specific signals from the gut that can influence hepatic immunity.

Key Results

  • Antibiotic Treatment Impairs Host Defense: Mice treated with antibiotics (disrupted gut microbiota) showed significantly reduced survival rates, increased bacterial burden in the liver and kidneys, and more severe liver damage following S. aureus infection.
  • Gut Microbiota Promotes Neutrophil Recruitment: Disruption of the gut microbiota led to a marked reduction in neutrophil infiltration into the liver.
  • IL-17A is Essential: Mice lacking IL-17A (Il17a<sup>-/-</sup>) had significantly lower survival rates and higher bacterial loads, regardless of antibiotic treatment, indicating IL-17A's critical role.
  • γδ T Cells are the Primary Source of IL-17A: In antibiotic-treated mice, hepatic γδ T cells, but not conventional Th17 cells, showed reduced IL-17A production, and Tcrδ<sup>-/-</sup> mice were highly susceptible to infection.
  • L. reuteri Rescues Host Defense: Supplementation with L. reuteri in antibiotic-treated mice significantly improved survival, reduced bacterial burden, and restored hepatic γδ T17 cell and neutrophil populations.
  • Indole Metabolites Mimic Protective Effects: Administration of indole metabolites to antibiotic-treated mice improved survival and reduced bacterial loads, highlighting their role as key microbial signals.

Limitations and Future Work

  • Early Stage Focus: The study primarily investigated the early stages of infection. The long-term effects of gut microbiota modulation on adaptive immune responses and chronic S. aureus infections were not explored.
  • Microbial Diversity and Composition: While L. reuteri was identified, the precise contributions of other commensal species and the impact of varying microbial diversity and community structures on the γδ T17-neutrophil axis warrant further investigation.
  • Mechanism of L. reuteri Action: The exact molecular mechanisms by which L. reuteri activates γδ T cells are still unclear, and indirect effects mediated by other commensals cannot be excluded.
  • Neutrophil-Other Immune Cell Interactions: Neutrophils collaborate with other liver immune cells, such as Kupffer cells, in clearing pathogens. Future work could explore these complex interactions.
  • Translational Potential: While promising, further research is needed to translate these findings into clinical applications, such as precision microbiome interventions for at-risk populations.

Summary updated

Abstract

<i>Staphylococcus aureus</i> (<i>S. aureus</i>) bloodstream infections pose a significant clinical threat, exacerbated by increasing antibiotic resistance and high mortality. While the gut microbiota is recognized as a key modulator of systemic immunity, the mechanisms underlying its protective role against invasive bacterial infections remain incompletely understood. Here, we investigated how gut microbiota influences hepatic immune responses during early <i>S. aureus</i> bloodstream infection using animal models. Our findings demonstrate that the gut microbiota exerts a protective effect against systemic <i>S. aureus</i> infection. Specifically, commensal microbiota-derived signals prime hepatic γδ T cells for rapid interleukin-17A (IL-17A) production upon bacterial challenge. This microbiota-dependent IL-17A response subsequently promotes neutrophil recruitment to the liver, facilitating bacterial clearance and limiting systemic dissemination. Disruption of the gut microbiota impaired hepatic γδ T cell IL-17A production, reduced neutrophil mobilization, and compromised host resistance to infection. Notably, we found that colonization with the commensal <i>Limosilactobacillus reuteri</i> (<i>L. reuteri)</i> activates this hepatic γδT17-neutrophil axis, enhancing host defense against <i>S. aureus</i> as a mechanism involving indole metabolites. This study reveals a novel gut-liver axis whereby intestinal microbiota orchestrates hepatic γδ T cell function to establish an early immunological barrier against invasive bacterial pathogens, offering potential therapeutic avenues for enhancing host defense against life-threatening <i>S. aureus</i> infections.
BibTeX
@inproceedings{pan2026gut,
  author = {Na Pan and Xing Su and Yifei Meng and Yanchen Liang and Xiye Chen and Haochi Zhang and Y. N. Wang},
  title = {{Gut microbiota-driven IL-17A production by hepatic γδ T cells enhances neutrophil defense against systemic <i>Staphylococcus aureus</i> infection}},
  booktitle = {Virulence},
  year = {2026},
  doi = {10.1080/21505594.2026.2629132},
}
Figure